GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alaunos Therapeutics Inc (FRA:WEK) » Definitions » Policyholder Funds

Alaunos Therapeutics (FRA:WEK) Policyholder Funds


View and export this data going back to 2006. Start your Free Trial

What is Alaunos Therapeutics Policyholder Funds?

Policyholder Funds only applies to insurance companies.


Alaunos Therapeutics (FRA:WEK) Business Description

Traded in Other Exchanges
Address
8030 El Rio Street, Houston, TX, USA, 77054
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens (neoAg) arising from genomic mutations.